AMSTERDAM (AP) — AMSTERDAM (AP) — UniQure NV (QURE) on Tuesday reported a loss of $44.4 million in its third quarter.

The Amsterdam-based company said it had a loss of 91 cents per share.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.12 per share.

The human gene therapy company posted revenue of $2.3 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $2.7 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on QURE at https://www.zacks.com/ap/QURE